Corazon (Corsee) D. Sanders
Sits on 4 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 4 boards, counting each seat separately. Longest: Ultragenyx Pharmaceutical Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ultragenyx Pharmaceutical Inc. June 18, 202491.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −2,000 | $25.05 | $50,100 |
| May 22, 2026 | BeOne Medicines Ltd. | Open-market sale | −212 | $309.59 | $65,633 |
| May 14, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +7,751 | — | — |
| Nov 26, 2025 | BeOne Medicines Ltd. | Option exercise | +2,627 | $159.03 | $417,772 |
| Nov 26, 2025 | BeOne Medicines Ltd. | Open-market sale | −1,823 | $340.20 | $620,185 |
| Nov 26, 2025 | BeOne Medicines Ltd. | Open-market sale | −804 | $342.47 | $275,346 |
| Sep 5, 2025 | BeOne Medicines Ltd. | Option exercise | +2,665 | $155.68 | $414,887 |
| Sep 5, 2025 | BeOne Medicines Ltd. | Open-market sale | −2,665 | $337.00 | $898,105 |
| Jun 20, 2025 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −2,405 | $37.39 | $89,923 |
| May 21, 2025 | BeOne Medicines Ltd. | Grant or award | +10,985 | — | — |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +5,740 | — | — |
| Jul 2, 2024 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −584 | $40.98 | $23,932 |
| Jun 18, 2024 | Ultragenyx Pharmaceutical Inc. | Grant or award | +5,345 | — | — |
| Jun 10, 2024 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −1,737 | $41.10 | $71,391 |
| Jun 5, 2024 | BeOne Medicines Ltd. | Grant or award | +16,341 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.